Autoinflammatory Flashcards
Epidemiology of Behcets
- More common in Middle Eastern (Turkey), Japanese population
- F>M
- 20-35 age group
Pathogenesis of Behcets
- Precipitating factors:
- Infectious - HSV/HCV/Strep
- Genes - HLA B51
- Results in circulating immune complexes and neutrophils —> inflammatory cell infiltration
Clinical features of Behcets
- Cutaneous - OSAGE
- Oral apthosis
- Superficial thrombophlebitis
- Acral and facial pustules
- Genital apthosis
- Erythema nodosum
- Systemic - CVJARGON
- Cardiac
- Vascular
- Joints - 50% patients
- Renal
- GIT - abdominal pain, ulcers
- Ocular - 90% - uveitis, conjunctivitis
- Neuro - later onset, meningo-encephalitis
How do you diagnose Behcets?
Diagnosis
- 1 major and 2 minor criteria
- 1 major: oral aphtosis at least 3 in 12 months
- Minor:
- Genital
- Pathergy
- EN or papulopustular
- Ocular
How do you treat Behcets?
Treatment
- Topical steroids
- Systemic steroids
- Can try cyclosporin or azathioprine
- If really severe - TNF alpha and MTX
- If just mucocutaneous - dapsone and colchicine
What is the epidemiology of PAN?
- 4-16 per 100 000
- Male more than female
- Cutaneous - 10% kids
What is the pathogenesis and associations of PAN?
- Inflammation of medium sized blood vessels
- Unknown exact cause
- Associations:
- Infectous
- HBV 7%
- HCV
- Cutaneous only - P19
- Medications
- Minocycline
- Malignancy
- Hairy cell leukaemia
- Autoimmune
- IBD
- Rheumatoid arthritis
- Infectous
What are the cutaneous features of PAN?
- Livedo racemosa
- Subcutaneous nodules
- Retiform purpura
- Ulcers
What are the extra-cutaneous features of PAN?
- Lungs are spared
- Kidneys
- CNS - paraesthesias
- Gastro - abdominal pain, mesenteric ischaemia
- Rheum - arthralgia
- Cardio - cardiac failure
What does cutaneous PAN look like?
- 10% of cases
- Painful S/C nodules, livedo, cutaneous necrosis, ulcers
- Systemic: fevers, myalgia, arthralgia, peripheral neuropathy
- When cutaneous resolves, leaves retiform hyperpigmentation
Investigations for PAN and findings?
- Biopsy
- Segmental necrosing vasculitis of the medium sized vessels
- C3, fibrin and IgM positive
- Leukocytosis
- Elevated ESR and CRP
- Elevated platelets
- ANCA (rare)
- Micro aneurysms on MRA
Treatment of PAN?
- Classic - steroids 1 mg/kg, taper over 6 months, and cyclophosphamide if severe
- Cutaneous
- NSAIDs, topical/IL steroids
- MTX/dapsone, IVIG
- Colchicine, azathioprine
What are the types of lupus according to the depth of the skin?
- Acute cutaneous lupus- involves epidermis and maybe upper dermis
- SCLE- involves epidermis and upper-mid dermis
- Discoid lupus- predominantly dermal, with epidermal changes, and particularly peri-adnexal
- Tumid lupus- Superficial and deep dermal
- Panniculitis lupus- subcutaneous involvement
Associated conditions of DLE
- Thyomyoma
- Myasthenia gravis
- Pemphigus
- PCT
Medications that can cause DLE
penicallamine, isoniazid, griseofulvin, dapsone
Cutaneous findings of DLE
- Localised
- Head and neck
- Indurated, discoid lesions
- Dyspigmentation
- 1/3 have alopecia
- 1/3 have prominent follicular openings in ears
- Scarring (cribriform)
- Usually to lateral cheeks, nasal bridge
- 7.5% present with papulopustular - like rosacea- Disseminated
- More recalcitrant to treatment
- Torso and limbs
- Multiple types: bullous, annular
- Purple plaques on dorsums of hands
- Disseminated
- Rarely, at risk of SCC
Risk of DLE transformation to SLE
5-15%
SCLE clinical signs
- Photo-distributed pattern
- Annular, raised red border and central clearing
- No induration
- Borders may show vesícula tino and crusting and occasional bullae
- Lesions resolves to leave grey-white hypopigmentation and telangiectases
- Diffuse non-scarring alopecia
- Photosensitivity- half of patients
- Mouth ulceration
- Peri-ungual telangiectasia
- Reticular lívido
- Complications
- Urticaria vasculitis
- Chronic interstitial pneumonitis
- Hypokalaemia tetraparesis
- Malignancy (rare): breast, meningioma, hepatocellcular, Hodgkin, lung, prostate, SCC
Medications associated with SCLE
- Certain medications can cause: HCT, terbinafine, calcium channel blockers, NSAIDs, griseofulvin, histamines - TTCHANGE
- Up to 65% are caused by drugs
Risk of SCLE turning into SLE
10-15%
ACLE clinical findings
- Malar rash following sun exposure, resolve without scarring
- Presence of telangiectasias, erosions, dyspigmentation and epidermal atrophy may assist with dx
- May last from few hours to several week
- If on hands, knuckles are spared
- Rarely, develop reaction similar to TEN
- Can have just localised, more commonly associated with active SLE
Lupus panniculitis clinical findings
- Distributed to face, upper arms, upper trunk, breasts, buttocks and thighs
- Occasionally have discoid lesions over the top
Lupus panniculitis risk of turning into SLE
35%
Chillblain lupus findings
- Red or dusky purple papules and plaques on the toes, fingers and sometimes the nose, elbows, knees and lower legs
- Worse in the cold
- May be ordinary chilblains with LE
- Associated with DLE